Search

Many effective methods extract and fuse different protein features to study the relationship between protein sequence, structure, and function, but different methods have preferences in solving the research of protein structure and function, which requires selecting valuable and contributing features to design more effective prediction methods. This work mainly focused on the feature selection methods in the study of protein structure and function, and systematically compared and analyzed the efficiency of different feature selection methods in the prediction of protein structures, protein disorders, protein molecular chaperones, and protein solubility. The results show that the feature selection method based on nonlinear SVM performs best in protein structure prediction, protein solubility prediction, protein molecular chaperone prediction, and protein solubility prediction. After selection, the accuracy of features is improved by 13.16% ~71%, especially the Kmer features and PSSM features of proteins. [ABSTRACT FROM AUTHOR]

Drug-disease correlations play an important role in revealing the mechanism of disease, finding new indications of available drugs, or drug repositioning. A variety of computational approaches were proposed to find drug-disease correlations and achieve good performances. However, these methods used a variety of network information, but integrated networks were rarely used. In addition, the role of known drug-disease association data has not been fully played. In this work, we designed a combination algorithm of random walk and supervised learning to find the drug-disease correlations. We used an integrated network to update the model and selected a gene set as the start of random walk based on the known drug-disease correlations data. The experimental results show that the proposed method can effectively find the correlation between drugs and diseases, and the prediction accuracy is 82.7%. We found that there are 8 pairs of drug-disease relationships that have not yet been reported, and 5 of them have pharmacodynamic effects on Parkinson's disease. We also found that a key linkage between Parkinson's disease and phenylhexol, a drug for the treatment of Parkinson's disease α-synuclein and tau protein, provides a useful exploration for the effectiveness of the treatment of Parkinson's disease. [ABSTRACT FROM AUTHOR]